Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Vitamin D receptor | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma japonicum | Probable nuclear hormone receptor HR3, putative | Vitamin D receptor | 423 aa | 421 aa | 24.2 % |
Schistosoma mansoni | retinoic acid receptor RXR | Vitamin D receptor | 423 aa | 411 aa | 25.8 % |
Echinococcus granulosus | ecdysone induced protein 78C | Vitamin D receptor | 423 aa | 422 aa | 25.1 % |
Onchocerca volvulus | Putative trans-2-enoyl-CoA reductase 1, mitochondrial | Vitamin D receptor | 423 aa | 402 aa | 23.4 % |
Onchocerca volvulus | C-mannosyltransferase dpy-19 homolog | Vitamin D receptor | 423 aa | 394 aa | 30.2 % |
Brugia malayi | ecdysteroid receptor | Vitamin D receptor | 423 aa | 397 aa | 28.5 % |
Loa Loa (eye worm) | hypothetical protein | Vitamin D receptor | 423 aa | 379 aa | 30.9 % |
Brugia malayi | nuclear hormone receptor | Vitamin D receptor | 423 aa | 381 aa | 23.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | retinoic acid receptor rxr beta a | 0.0012 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.5 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-41 | 0.0012 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.5 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-1 | 0.0012 | 0.5 | 0.5 |
Echinococcus multilocularis | FTZ F1 nuclear receptor protein | 0.0012 | 0.5 | 0.5 |
Schistosoma mansoni | thyroid hormone receptor | 0.0012 | 0.5 | 0.5 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.0012 | 0.5 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-25 | 0.0012 | 0.5 | 0.5 |
Echinococcus multilocularis | COUP TF:Svp nuclear hormone receptor | 0.0012 | 0.5 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-31 | 0.0012 | 0.5 | 0.5 |
Schistosoma mansoni | retinoic acid receptor RXR | 0.0012 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.5 | 0.5 |
Onchocerca volvulus | 0.0012 | 0.5 | 0.5 | |
Echinococcus granulosus | hepatocyte nuclear factor 4 alpha | 0.0012 | 0.5 | 0.5 |
Onchocerca volvulus | Bile acid receptor homolog | 0.0012 | 0.5 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-3 | 0.0012 | 0.5 | 0.5 |
Echinococcus multilocularis | hepatocyte nuclear factor 4 alpha | 0.0012 | 0.5 | 0.5 |
Echinococcus multilocularis | Nuclear hormone receptor family member nhr 41 | 0.0012 | 0.5 | 0.5 |
Schistosoma mansoni | retinoid-x-receptor (RXR) | 0.0012 | 0.5 | 0.5 |
Schistosoma mansoni | steroid hormone receptor ad4bp | 0.0012 | 0.5 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-49 | 0.0012 | 0.5 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-31 | 0.0012 | 0.5 | 0.5 |
Echinococcus granulosus | FTZ F1 nuclear receptor protein | 0.0012 | 0.5 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-25 | 0.0012 | 0.5 | 0.5 |
Echinococcus granulosus | COUP TF:Svp nuclear hormone receptor | 0.0012 | 0.5 | 0.5 |
Schistosoma mansoni | coup transcription factor | 0.0012 | 0.5 | 0.5 |
Brugia malayi | photoreceptor-specific nuclear receptor | 0.0012 | 0.5 | 0.5 |
Schistosoma mansoni | thyroid hormone receptor | 0.0012 | 0.5 | 0.5 |
Schistosoma mansoni | RAR-like nuclear receptor | 0.0012 | 0.5 | 0.5 |
Loa Loa (eye worm) | steroid hormone receptor | 0.0012 | 0.5 | 0.5 |
Schistosoma mansoni | nuclear receptor 2DBD-gamma | 0.0012 | 0.5 | 0.5 |
Loa Loa (eye worm) | nuclear Hormone Receptor family member | 0.0012 | 0.5 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-49 | 0.0012 | 0.5 | 0.5 |
Brugia malayi | Ligand-binding domain of nuclear hormone receptor family protein | 0.0012 | 0.5 | 0.5 |
Schistosoma mansoni | Tr4/Tr2 (homologue) | 0.0012 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.5 | 0.5 |
Echinococcus granulosus | ecdysone induced protein 78C | 0.0012 | 0.5 | 0.5 |
Echinococcus multilocularis | nuclear receptor 2DBD gamma | 0.0012 | 0.5 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-40 | 0.0012 | 0.5 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-1 | 0.0012 | 0.5 | 0.5 |
Brugia malayi | steroid hormone receptor | 0.0012 | 0.5 | 0.5 |
Brugia malayi | nuclear hormone receptor | 0.0012 | 0.5 | 0.5 |
Brugia malayi | Ligand-binding domain of nuclear hormone receptor family protein | 0.0012 | 0.5 | 0.5 |
Echinococcus multilocularis | FTZ F1 alpha | 0.0012 | 0.5 | 0.5 |
Echinococcus granulosus | nuclear receptor 2DBD gamma | 0.0012 | 0.5 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-41 | 0.0012 | 0.5 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-19 | 0.0012 | 0.5 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-40 | 0.0012 | 0.5 | 0.5 |
Schistosoma mansoni | nuclear hormone receptor nor-1/nor-2 | 0.0012 | 0.5 | 0.5 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-14 | 0.0012 | 0.5 | 0.5 |
Echinococcus granulosus | FTZ F1 alpha | 0.0012 | 0.5 | 0.5 |
Echinococcus granulosus | Nuclear hormone receptor family member nhr 41 | 0.0012 | 0.5 | 0.5 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.0012 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.5 | 0.5 |
Brugia malayi | nuclear receptor NHR-88 | 0.0012 | 0.5 | 0.5 |
Echinococcus multilocularis | nuclear receptor 2DBD gamma | 0.0012 | 0.5 | 0.5 |
Brugia malayi | Nuclear hormone receptor-like 1 | 0.0012 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.5 | 0.5 |
Schistosoma mansoni | photoreceptor-specific nuclear receptor related | 0.0012 | 0.5 | 0.5 |
Echinococcus granulosus | nuclear receptor 2DBD gamma | 0.0012 | 0.5 | 0.5 |
Echinococcus multilocularis | ecdysone induced protein 78C | 0.0012 | 0.5 | 0.5 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.0012 | 0.5 | 0.5 |
Brugia malayi | Steroid receptor seven-up type 2 | 0.0012 | 0.5 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-14 | 0.0012 | 0.5 | 0.5 |
Schistosoma mansoni | FTZ-F1 nuclear receptor-like protein | 0.0012 | 0.5 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-19 | 0.0012 | 0.5 | 0.5 |
Schistosoma mansoni | nuclear hormone receptor | 0.0012 | 0.5 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | Increase in serum calcium in vitamin D sufficient CD1 mouse at 150 ug/kg, po | ChEMBL. | 17960924 | |
Activity (functional) | Increase in serum calcium in vitamin D deficient CD1 mouse at 5.4 ug/mg, ip after 24 hrs | ChEMBL. | 17960924 | |
Activity (binding) | Activity at VDR in rat osteosarcoma cells assessed as 24-hydroxylase transcription by reporter gene assay | ChEMBL. | 17960924 | |
Activity (functional) | Increase in serum calcium in vitamin D sufficient CD1 mouse at 150 ug/kg, ip | ChEMBL. | 17960924 | |
Activity (functional) | Increase in serum calcium in vitamin D sufficient CD1 mouse at 50 ug/kg, ip | ChEMBL. | 17960924 | |
Activity (functional) | Increase in serum calcium in vitamin D sufficient CD1 mouse at 33.3 ug/kg, po | ChEMBL. | 17960924 | |
Activity (functional) | Increase in serum calcium in vitamin D deficient CD1 mouse at 181.5 ug/mg, ip after 24 hrs | ChEMBL. | 17960924 | |
Activity (functional) | Increase in serum calcium in vitamin D sufficient CD1 mouse at 33.3 ug/kg, ip | ChEMBL. | 17960924 | |
Activity (binding) | 0 | Activity at VDR in rat osteosarcoma cells assessed as 24-hydroxylase transcription by reporter gene assay | ChEMBL. | 17960924 |
Activity (functional) | 0 | Increase in serum calcium in vitamin D deficient CD1 mouse at 5.4 ug/mg, ip after 24 hrs | ChEMBL. | 17960924 |
Activity (functional) | 0 | Increase in serum calcium in vitamin D deficient CD1 mouse at 181.5 ug/mg, ip after 24 hrs | ChEMBL. | 17960924 |
Activity (functional) | 0 | Increase in serum calcium in vitamin D sufficient CD1 mouse at 50 ug/kg, ip | ChEMBL. | 17960924 |
Activity (functional) | 0 | Increase in serum calcium in vitamin D sufficient CD1 mouse at 150 ug/kg, ip | ChEMBL. | 17960924 |
Activity (functional) | 0 | Increase in serum calcium in vitamin D sufficient CD1 mouse at 33.3 ug/kg, ip | ChEMBL. | 17960924 |
Activity (functional) | 0 | Increase in serum calcium in vitamin D sufficient CD1 mouse at 33.3 ug/kg, po | ChEMBL. | 17960924 |
Activity (functional) | 0 | Increase in serum calcium in vitamin D sufficient CD1 mouse at 150 ug/kg, po | ChEMBL. | 17960924 |
EC50 (binding) | = 1 10^-5M | Displacement of 1alpha,25-dihydroxyvitamin from rat recombinant VDR | ChEMBL. | 17960924 |
EC50 (binding) | = 1 10^-5M | Displacement of 1alpha,25-dihydroxyvitamin from rat recombinant VDR | ChEMBL. | 17960924 |
EC50 (functional) | = 1 10^-6M | Induction of differention of human HL60 cells into monocytes by NBT reduction assay | ChEMBL. | 17960924 |
EC50 (functional) | = 1 10^-6M | Induction of differention of human HL60 cells into monocytes by NBT reduction assay | ChEMBL. | 17960924 |
Ratio ED50 (binding) | > 1000000 | Ratio of ED50 for drug to 1alpha,25-dihydroxyvitamin for rat recombinant VDR | ChEMBL. | 17960924 |
Ratio ED50 (functional) | > 1000 | Ratio of ED50 for drug to 1alpha,25-dihydroxyvitamin for HL60 cells differentitaion by NBT reduction assay | ChEMBL. | 17960924 |
Ratio ED50 (binding) | > 1000000 | Ratio of ED50 for drug to 1alpha,25-dihydroxyvitamin for rat recombinant VDR | ChEMBL. | 17960924 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 17960924 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.